Loading…

Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion

Background Resistant organisms are difficult to eradicate in infected total knee arthroplasty. While most surgeons use antibiotic-impregnated cement in these revisions, the delivery of the drug in adequate doses is limited in penetration and duration. Direct infusion is an alternate technique. Quest...

Full description

Saved in:
Bibliographic Details
Published in:Clinical orthopaedics and related research 2011-01, Vol.469 (1), p.26-33
Main Authors: Whiteside, Leo A., Peppers, Michael, Nayfeh, Tariq A., Roy, Marcel E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3
cites cdi_FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3
container_end_page 33
container_issue 1
container_start_page 26
container_title Clinical orthopaedics and related research
container_volume 469
creator Whiteside, Leo A.
Peppers, Michael
Nayfeh, Tariq A.
Roy, Marcel E.
description Background Resistant organisms are difficult to eradicate in infected total knee arthroplasty. While most surgeons use antibiotic-impregnated cement in these revisions, the delivery of the drug in adequate doses is limited in penetration and duration. Direct infusion is an alternate technique. Questions/purposes We asked whether single-stage revision and direct antibiotic infusion for infected TKA would control infection in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Methods We retrospectively reviewed 18 patients (18 knees) with MRSA with one-stage revision protocol that included débridement, uncemented revision of total knee components, and intraarticular infusion of 500 mg vancomycin via Hickman catheter once or twice daily for 6 weeks; we used no intravenous antibiotics after the first 24 hours. We monitored serum vancomycin levels to maintain levels between 3 and 10 μg/mL. Minimum followup was 27 months (range, 27–75 months). Mean followup was 62 months, (range, 27–96 months). Results Infection was controlled at last followup in all but one patient with a recurrence of the MRSA. The patient was reoperated at 5 months; a necrotic bone fragment was removed, the knee was débrided and revised, and the antibiotic infusion protocol readministered. The patient remained free of infection 42 months postoperatively. At 2-year followup, the mean Knee Society score was 83. We observed no radiographic evidence of implant migration. Conclusions One-stage revision and 6 weeks of intraarticular vancomycin administration controlled infection in MRSA infected TKA with no apparent complications. Level of Evidence Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
doi_str_mv 10.1007/s11999-010-1313-9
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3008903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1011206583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3</originalsourceid><addsrcrecordid>eNp1UU2LFDEUDKK4s6M_wFvw5KXXl6Q_koswrF-LK4KO6C28Tqd3svQks0l6YP-9aWZRFDwVxasq6lGEvGBwwQC614kxpVQFDCommKjUI7JiDZcVY4I_JisAUJXi7OcZOU_ptlBRN_wpOeMgFNQdX5HjZ5t3zrhpcr6KNrmU0Wf6LeNhdz8FE4yZE8U52gLO0-2nDd1Gi9kO9IfLO_rVHl1ywVP0A33rojWZXvkcEWN2Zp4w0o3Prneh0HIZ50X9jDwZcUr2-QOuyff377aXH6vrLx-uLjfXlanrNlcM2ShHg0r0wjbSqK7rxdCC6uqhByU479pBWmFbFLUwEntT49iPZhQGzTCINXlzyj3M_d4Oxi7NJn2Ibo_xXgd0-u-Ldzt9E45aAEgFogS8egiI4W62Keu9S8ZOE3ob5qQZMMahbeQiffmP9DbM0Zf3tKylVKopHdeEnUQmhpSiHX93YaCXUfVpVA0LL6NqVTz85ElF629s_BP8f9MvXe-m3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>848899534</pqid></control><display><type>article</type><title>Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion</title><source>PubMed Central</source><creator>Whiteside, Leo A. ; Peppers, Michael ; Nayfeh, Tariq A. ; Roy, Marcel E.</creator><creatorcontrib>Whiteside, Leo A. ; Peppers, Michael ; Nayfeh, Tariq A. ; Roy, Marcel E.</creatorcontrib><description>Background Resistant organisms are difficult to eradicate in infected total knee arthroplasty. While most surgeons use antibiotic-impregnated cement in these revisions, the delivery of the drug in adequate doses is limited in penetration and duration. Direct infusion is an alternate technique. Questions/purposes We asked whether single-stage revision and direct antibiotic infusion for infected TKA would control infection in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Methods We retrospectively reviewed 18 patients (18 knees) with MRSA with one-stage revision protocol that included débridement, uncemented revision of total knee components, and intraarticular infusion of 500 mg vancomycin via Hickman catheter once or twice daily for 6 weeks; we used no intravenous antibiotics after the first 24 hours. We monitored serum vancomycin levels to maintain levels between 3 and 10 μg/mL. Minimum followup was 27 months (range, 27–75 months). Mean followup was 62 months, (range, 27–96 months). Results Infection was controlled at last followup in all but one patient with a recurrence of the MRSA. The patient was reoperated at 5 months; a necrotic bone fragment was removed, the knee was débrided and revised, and the antibiotic infusion protocol readministered. The patient remained free of infection 42 months postoperatively. At 2-year followup, the mean Knee Society score was 83. We observed no radiographic evidence of implant migration. Conclusions One-stage revision and 6 weeks of intraarticular vancomycin administration controlled infection in MRSA infected TKA with no apparent complications. Level of Evidence Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.</description><identifier>ISSN: 0009-921X</identifier><identifier>EISSN: 1528-1132</identifier><identifier>DOI: 10.1007/s11999-010-1313-9</identifier><identifier>PMID: 20390472</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Antibiotics ; Arthroplasty (knee) ; Bone ; Catheters ; Cement ; Conservative Orthopedics ; Drug delivery ; Drug resistance ; Infection ; Intravenous administration ; Knee ; Medicine ; Medicine &amp; Public Health ; Migration ; Orthopedics ; Sports Medicine ; Staphylococcus aureus ; Surgery ; Surgical Orthopedics ; Symposium: Papers Presented at the Annual Meetings of the Knee Society ; Vancomycin</subject><ispartof>Clinical orthopaedics and related research, 2011-01, Vol.469 (1), p.26-33</ispartof><rights>The Association of Bone and Joint Surgeons® 2010</rights><rights>The Association of Bone and Joint Surgeons® 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3</citedby><cites>FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008903/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008903/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Whiteside, Leo A.</creatorcontrib><creatorcontrib>Peppers, Michael</creatorcontrib><creatorcontrib>Nayfeh, Tariq A.</creatorcontrib><creatorcontrib>Roy, Marcel E.</creatorcontrib><title>Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><description>Background Resistant organisms are difficult to eradicate in infected total knee arthroplasty. While most surgeons use antibiotic-impregnated cement in these revisions, the delivery of the drug in adequate doses is limited in penetration and duration. Direct infusion is an alternate technique. Questions/purposes We asked whether single-stage revision and direct antibiotic infusion for infected TKA would control infection in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Methods We retrospectively reviewed 18 patients (18 knees) with MRSA with one-stage revision protocol that included débridement, uncemented revision of total knee components, and intraarticular infusion of 500 mg vancomycin via Hickman catheter once or twice daily for 6 weeks; we used no intravenous antibiotics after the first 24 hours. We monitored serum vancomycin levels to maintain levels between 3 and 10 μg/mL. Minimum followup was 27 months (range, 27–75 months). Mean followup was 62 months, (range, 27–96 months). Results Infection was controlled at last followup in all but one patient with a recurrence of the MRSA. The patient was reoperated at 5 months; a necrotic bone fragment was removed, the knee was débrided and revised, and the antibiotic infusion protocol readministered. The patient remained free of infection 42 months postoperatively. At 2-year followup, the mean Knee Society score was 83. We observed no radiographic evidence of implant migration. Conclusions One-stage revision and 6 weeks of intraarticular vancomycin administration controlled infection in MRSA infected TKA with no apparent complications. Level of Evidence Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.</description><subject>Antibiotics</subject><subject>Arthroplasty (knee)</subject><subject>Bone</subject><subject>Catheters</subject><subject>Cement</subject><subject>Conservative Orthopedics</subject><subject>Drug delivery</subject><subject>Drug resistance</subject><subject>Infection</subject><subject>Intravenous administration</subject><subject>Knee</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Migration</subject><subject>Orthopedics</subject><subject>Sports Medicine</subject><subject>Staphylococcus aureus</subject><subject>Surgery</subject><subject>Surgical Orthopedics</subject><subject>Symposium: Papers Presented at the Annual Meetings of the Knee Society</subject><subject>Vancomycin</subject><issn>0009-921X</issn><issn>1528-1132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1UU2LFDEUDKK4s6M_wFvw5KXXl6Q_koswrF-LK4KO6C28Tqd3svQks0l6YP-9aWZRFDwVxasq6lGEvGBwwQC614kxpVQFDCommKjUI7JiDZcVY4I_JisAUJXi7OcZOU_ptlBRN_wpOeMgFNQdX5HjZ5t3zrhpcr6KNrmU0Wf6LeNhdz8FE4yZE8U52gLO0-2nDd1Gi9kO9IfLO_rVHl1ywVP0A33rojWZXvkcEWN2Zp4w0o3Prneh0HIZ50X9jDwZcUr2-QOuyff377aXH6vrLx-uLjfXlanrNlcM2ShHg0r0wjbSqK7rxdCC6uqhByU479pBWmFbFLUwEntT49iPZhQGzTCINXlzyj3M_d4Oxi7NJn2Ibo_xXgd0-u-Ldzt9E45aAEgFogS8egiI4W62Keu9S8ZOE3ob5qQZMMahbeQiffmP9DbM0Zf3tKylVKopHdeEnUQmhpSiHX93YaCXUfVpVA0LL6NqVTz85ElF629s_BP8f9MvXe-m3Q</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Whiteside, Leo A.</creator><creator>Peppers, Michael</creator><creator>Nayfeh, Tariq A.</creator><creator>Roy, Marcel E.</creator><general>Springer-Verlag</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion</title><author>Whiteside, Leo A. ; Peppers, Michael ; Nayfeh, Tariq A. ; Roy, Marcel E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibiotics</topic><topic>Arthroplasty (knee)</topic><topic>Bone</topic><topic>Catheters</topic><topic>Cement</topic><topic>Conservative Orthopedics</topic><topic>Drug delivery</topic><topic>Drug resistance</topic><topic>Infection</topic><topic>Intravenous administration</topic><topic>Knee</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Migration</topic><topic>Orthopedics</topic><topic>Sports Medicine</topic><topic>Staphylococcus aureus</topic><topic>Surgery</topic><topic>Surgical Orthopedics</topic><topic>Symposium: Papers Presented at the Annual Meetings of the Knee Society</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whiteside, Leo A.</creatorcontrib><creatorcontrib>Peppers, Michael</creatorcontrib><creatorcontrib>Nayfeh, Tariq A.</creatorcontrib><creatorcontrib>Roy, Marcel E.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whiteside, Leo A.</au><au>Peppers, Michael</au><au>Nayfeh, Tariq A.</au><au>Roy, Marcel E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion</atitle><jtitle>Clinical orthopaedics and related research</jtitle><stitle>Clin Orthop Relat Res</stitle><date>2011-01-01</date><risdate>2011</risdate><volume>469</volume><issue>1</issue><spage>26</spage><epage>33</epage><pages>26-33</pages><issn>0009-921X</issn><eissn>1528-1132</eissn><abstract>Background Resistant organisms are difficult to eradicate in infected total knee arthroplasty. While most surgeons use antibiotic-impregnated cement in these revisions, the delivery of the drug in adequate doses is limited in penetration and duration. Direct infusion is an alternate technique. Questions/purposes We asked whether single-stage revision and direct antibiotic infusion for infected TKA would control infection in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Methods We retrospectively reviewed 18 patients (18 knees) with MRSA with one-stage revision protocol that included débridement, uncemented revision of total knee components, and intraarticular infusion of 500 mg vancomycin via Hickman catheter once or twice daily for 6 weeks; we used no intravenous antibiotics after the first 24 hours. We monitored serum vancomycin levels to maintain levels between 3 and 10 μg/mL. Minimum followup was 27 months (range, 27–75 months). Mean followup was 62 months, (range, 27–96 months). Results Infection was controlled at last followup in all but one patient with a recurrence of the MRSA. The patient was reoperated at 5 months; a necrotic bone fragment was removed, the knee was débrided and revised, and the antibiotic infusion protocol readministered. The patient remained free of infection 42 months postoperatively. At 2-year followup, the mean Knee Society score was 83. We observed no radiographic evidence of implant migration. Conclusions One-stage revision and 6 weeks of intraarticular vancomycin administration controlled infection in MRSA infected TKA with no apparent complications. Level of Evidence Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>20390472</pmid><doi>10.1007/s11999-010-1313-9</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-921X
ispartof Clinical orthopaedics and related research, 2011-01, Vol.469 (1), p.26-33
issn 0009-921X
1528-1132
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3008903
source PubMed Central
subjects Antibiotics
Arthroplasty (knee)
Bone
Catheters
Cement
Conservative Orthopedics
Drug delivery
Drug resistance
Infection
Intravenous administration
Knee
Medicine
Medicine & Public Health
Migration
Orthopedics
Sports Medicine
Staphylococcus aureus
Surgery
Surgical Orthopedics
Symposium: Papers Presented at the Annual Meetings of the Knee Society
Vancomycin
title Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A40%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methicillin-resistant%20Staphylococcus%20aureus%20in%20TKA%20Treated%20With%20Revision%20and%20Direct%20Intraarticular%20Antibiotic%20Infusion&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=Whiteside,%20Leo%20A.&rft.date=2011-01-01&rft.volume=469&rft.issue=1&rft.spage=26&rft.epage=33&rft.pages=26-33&rft.issn=0009-921X&rft.eissn=1528-1132&rft_id=info:doi/10.1007/s11999-010-1313-9&rft_dat=%3Cproquest_pubme%3E1011206583%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446t-1a1f8fca93b3e58c977b3d60974db0932276d8e3e6a343c8abc4afbfcf3cacdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=848899534&rft_id=info:pmid/20390472&rfr_iscdi=true